Literature DB >> 28648597

Genotype-phenotype correlation for congenital heart disease in Down syndrome through analysis of partial trisomy 21 cases.

Maria Chiara Pelleri1, Elena Gennari2, Chiara Locatelli2, Allison Piovesan1, Maria Caracausi1, Francesca Antonaros1, Alessandro Rocca2, Costanza Maria Donati2, Letizia Conti2, Pierluigi Strippoli1, Marco Seri3, Lorenza Vitale4, Guido Cocchi5.   

Abstract

Among Down syndrome (DS) children, 40-50% have congenital heart disease (CHD). Although trisomy 21 is not sufficient to cause CHD, three copies of at least part of chromosome 21 (Hsa21) increases the risk for CHD. In order to establish a genotype-phenotype correlation for CHD in DS, we built an integrated Hsa21 map of all described partial trisomy 21 (PT21) cases with sufficient indications regarding presence or absence of CHD (n=107), focusing on DS PT21 cases. We suggest a DS CHD candidate region on 21q22.2 (0.96Mb), being shared by most PT21 cases with CHD and containing three known protein-coding genes (DSCAM, BACE2, PLAC4) and four known non-coding RNAs (DSCAM-AS1, DSCAM-IT1, LINC00323, MIR3197). The characterization of a DS CHD candidate region provides a useful approach to identify specific genes contributing to the pathology and to orient further investigations and possibly more effective therapy in relation to the multifactorial pathogenesis of CHD.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital heart disease; Down syndrome; Human chromosome 21; Partial trisomy 21

Mesh:

Substances:

Year:  2017        PMID: 28648597     DOI: 10.1016/j.ygeno.2017.06.004

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  10 in total

1.  Partial trisomy 21 map: Ten cases further supporting the highly restricted Down syndrome critical region (HR-DSCR) on human chromosome 21.

Authors:  Maria Chiara Pelleri; Elena Cicchini; Michael B Petersen; Lisbeth Tranebjaerg; Teresa Mattina; Pamela Magini; Francesca Antonaros; Maria Caracausi; Lorenza Vitale; Chiara Locatelli; Marco Seri; Pierluigi Strippoli; Allison Piovesan; Guido Cocchi
Journal:  Mol Genet Genomic Med       Date:  2019-06-25       Impact factor: 2.183

Review 2.  New Molecular and Organelle Alterations Linked to Down Syndrome Heart Disease.

Authors:  Leslye Venegas-Zamora; Francisco Bravo-Acuña; Francisco Sigcho; Wileidy Gomez; José Bustamante-Salazar; Zully Pedrozo; Valentina Parra
Journal:  Front Genet       Date:  2022-01-18       Impact factor: 4.599

3.  A reassessment of Jackson's checklist and identification of two Down syndrome sub-phenotypes.

Authors:  Chiara Locatelli; Sara Onnivello; Caterina Gori; Giuseppe Ramacieri; Francesca Pulina; Chiara Marcolin; Renzo Vianello; Beatrice Vione; Maria Caracausi; Maria Chiara Pelleri; Lorenza Vitale; Gian Luca Pirazzoli; Guido Cocchi; Luigi Corvaglia; Pierluigi Strippoli; Francesca Antonaros; Allison Piovesan; Silvia Lanfranchi
Journal:  Sci Rep       Date:  2022-02-24       Impact factor: 4.379

4.  Genome-wide methylation patterns in Marfan syndrome.

Authors:  Aeilko H Zwinderman; Vivian de Waard; Mitzi M van Andel; Maarten Groenink; Maarten P van den Berg; Janneke Timmermans; Arthur J H A Scholte; Barbara J M Mulder
Journal:  Clin Epigenetics       Date:  2021-12-11       Impact factor: 6.551

5.  Is the Age of Developmental Milestones a Predictor for Future Development in Down Syndrome?

Authors:  Chiara Locatelli; Sara Onnivello; Francesca Antonaros; Agnese Feliciello; Sonia Filoni; Sara Rossi; Francesca Pulina; Chiara Marcolin; Renzo Vianello; Enrico Toffalini; Giuseppe Ramacieri; Anna Martelli; Giulia Procaccini; Giacomo Sperti; Maria Caracausi; Maria Chiara Pelleri; Lorenza Vitale; Gian Luca Pirazzoli; Pierluigi Strippoli; Guido Cocchi; Allison Piovesan; Silvia Lanfranchi
Journal:  Brain Sci       Date:  2021-05-18

6.  Identifying Patients with Atrioventricular Septal Defect in Down Syndrome Populations by Using Self-Normalizing Neural Networks and Feature Selection.

Authors:  Xiaoyong Pan; Xiaohua Hu; Yu Hang Zhang; Kaiyan Feng; Shao Peng Wang; Lei Chen; Tao Huang; Yu Dong Cai
Journal:  Genes (Basel)       Date:  2018-04-12       Impact factor: 4.096

7.  Uncovering Potential lncRNAs and mRNAs in the Progression From Acute Myocardial Infarction to Myocardial Fibrosis to Heart Failure.

Authors:  Shuo Wang; Enmao Wang; Qincong Chen; Yan Yang; Lei Xu; Xiaolei Zhang; Rubing Wu; Xitian Hu; Zhihong Wu
Journal:  Front Cardiovasc Med       Date:  2021-07-16

8.  Structural Characterization of the Highly Restricted Down Syndrome Critical Region on 21q22.13: New KCNJ6 and DSCR4 Transcript Isoforms.

Authors:  Francesca Antonaros; Margherita Pitocco; Domenico Abete; Beatrice Vione; Allison Piovesan; Lorenza Vitale; Pierluigi Strippoli; Maria Caracausi; Maria Chiara Pelleri
Journal:  Front Genet       Date:  2021-12-08       Impact factor: 4.599

9.  Drug-Targeted Genomes: Mutability of Ion Channels and GPCRs.

Authors:  Regan Raines; Ian McKnight; Hunter White; Kaitlyn Legg; Chan Lee; Wei Li; Peter H U Lee; Joon W Shim
Journal:  Biomedicines       Date:  2022-03-03

Review 10.  Genomic frontiers in congenital heart disease.

Authors:  Sarah U Morton; Daniel Quiat; Jonathan G Seidman; Christine E Seidman
Journal:  Nat Rev Cardiol       Date:  2021-07-16       Impact factor: 49.421

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.